Update on Ikena Oncology Shares and IK-930 Cancer Drug
Ikena Oncology shares plunged after sharing initial data from their Phase I study for cancer drug IK-930. The drug showed a favorable safety profile w...
Ikena Oncology shares plunged after sharing initial data from their Phase I study for cancer drug IK-930. The drug showed a favorable safety profile w...
The interim president of the St. Louis Federal Reserve discusses the patient approach to interest rates and the importance of waiting for data.
Disney CEO Bob Iger is implementing cost-cutting measures to address challenges and boost stock performance. Analysts are cautiously optimistic about...
San Francisco's office space market is facing a divide, with high demand for premium offices overlooking the skyline but stagnant leasing activity for...
Canadian telecom giant Rogers Communications reports a loss in Q3 due to acquisition costs, but exceeds revenue expectations through successful integr...
Yeti Holdings Inc. exceeds earnings expectations, raises full-year outlook, and improves gross margin. Sales remain steady with increase in drinkware...
Shares of Myanmar Investments International have fallen after the company announced its intention to propose the cancellation of shares and sell off r...
Morgan Advanced Materials reports sales growth in first nine months and margin improvement despite challenges. Company focuses on cost-cutting and exp...
Angle PLC shares fall as full-year revenue projection falls short of market expectations. The company anticipates new sales in 2023 and a cost-saving...
Highlights from the recent Republican presidential debate on addressing inflation, featuring proposals from Governor Ron DeSantis and Senator Tim Scot...